Jackob Moskovitz

Jackob Moskovitz

Mar 09, 2019

Group 6 Copy 125
2
Please wait...

About This Project

Oxidized forms of the peptide beta-amyloid (Aβ) are considered to be toxic to the brain, leading to the development of Alzheimer's disease (AD). Based on our preliminary data, we hypothesize that an immunization of an AD-model mice with a recombinant protein enriched with the oxidized amino acid methionine sulfoxide will cause the removal of toxic Aβ from brain. Consequently, this treatment is expected to inhibit the development of AD and alleviate cognitive impairment.

Blast off!

Browse Other Projects on Experiment

Related Projects

Managing Congenital Adrenal Hyperplasia in the Amish Population

Congenital adrenal hyperplasia (CAH) is a disorder that affects the production of hormones critical for...

Can we Measure the Body's Response to Implants by Testing the Blood?

Would you or a loved one someday benefit from a life-saving medical implant? However, the organisms adapt...

A Leap Forward to Cure a Neglected Disease

The World Health Organization estimates that as many as 11 million people worldwide are infected with the...

Campaign Ended

A medicine project funded by 45 people